Woodman Richard Charles 4
4 · Onconova Therapeutics, Inc. · Filed Nov 7, 2018
Insider Transaction Report
Form 4
Woodman Richard Charles
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2018-11-05+20,000→ 20,000 totalExercise: $5.82Exp: 2028-11-05→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]These options vest over 4 years. 25% on the first anniversary of the grant date and the remainder in 36 equal monthly installments over the last 3 years.